Endocrinologia

M-A | Hipocalcemia após tireoidectomia em pacientes submetidos previamente à cirurgia bariátrica.

12 Set, 2022 | 11:10h

Hypocalcaemia following thyroidectomy among patients who have previously undergone bariatric surgery: systematic review and meta-analysis – British Journal of Surgery (link para o resumo – $ para o texto completo)

Estudo randomizado | Terapia em circuito fechado híbrido avançado vs. tratamento convencional em adultos com diabetes tipo 1.

8 Set, 2022 | 14:11h

Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study – The Lancet Endocrinology (link para o resumo – $ para o texto completo)

Comentário: ‘Artificial Pancreas’ Best in Poorly Controlled Type 1 Diabetes – Medscape (necessário cadastro gratuito)

Comentário no Twitter

New—Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 #diabetes (ADAPT): a randomised controlled study https://t.co/XrrmoDuQLy #T1D pic.twitter.com/GSLWA3xX7F

— The Lancet Diabetes & Endocrinology (@TheLancetEndo) September 2, 2022

Estudo randomizado | Somapacitam semanal é não inferior ao hormônio de crescimento (GH) diário em crianças com deficiência de GH.

8 Set, 2022 | 13:43h

Weekly Somapacitan is Effective and Well Tolerated in Children with GH Deficiency: The Randomized Phase 3 REAL4 Trial – The Journal of Clinical Endocrinology & Metabolism

Algoritmo australiano de tratamento da obesidade: uma ferramenta simples para orientar o tratamento da obesidade na atenção primária.

6 Set, 2022 | 13:04h

The Australian Obesity Management Algorithm: A simple tool to guide the management of obesity in primary care – Obesity Research & Clinical Practice

Doença hepática gordurosa não alcoólica: revisão do tratamento para provedores de atenção primária.

6 Set, 2022 | 12:45h

Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers – Mayo Clinic Proceedings

Atualização sobre o tratamento do diabetes em instituições de longa permanência.

29 Ago, 2022 | 17:49h

Update on the management of diabetes in long-term care facilities – BMJ Open Diabetes Research & Care

Estudo randomizado | Em pacientes com dor neuropática diabética, a amitriptilina suplementada com pregabalina, a pregabalina suplementada com amitriptilina e a duloxetina suplementada com pregabalina foram similarmente efetivas.

29 Ago, 2022 | 17:24h

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial – The Lancet

Comentário de estudo | Há evidências fortes para estimulação de medula espinal na neuropatia diabética? Nem todos os especialistas concordam.

29 Ago, 2022 | 16:56h

Is the Evidence Strong for Spinal Cord Stimulation for Diabetic Neuropathy? Not All Experts Agree – Neurology Today

Estudo original: RCT: Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy

Declaração de recomendação USPSTF | Uso de estatinas para prevenção primária de doença cardiovascular em adultos.

29 Ago, 2022 | 16:49h

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement – JAMA

Editoriais:

Statins for Primary Cardiovascular Disease Prevention: Time to Curb Our Enthusiasm – JAMA Internal Medicine

Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already? – JAMA Network Open

Relatório de evidência: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Entrevista com o autor: USPSTF Recommendation: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults – JAMA

Página do paciente: Statins for the Prevention of Cardiovascular Disease – JAMA

Comentário: Latest statins guidance keeps more conservative approach to preventing first stroke or heart attack – CNN

Adoçantes não nutritivos afetam microbiomas humanos e podem alterar respostas glicêmicas.

29 Ago, 2022 | 16:44h

Comunicado de imprensa: Non-nutritive sweeteners affect human microbiomes and can alter glycemic responses – Cell Press

Estudo original: Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance – Cell

Comentário: Expert reaction to study looking at the effect of non-nutritive sweeteners on human microbiomes and glycaemic levels – Science Media Centre